Position history for Carlyle Group Inc.'s holdings in PHATHOM PHARMACEUTICALS INC
Carlyle Group Inc. holds 3.5M shares of PHAT (PHATHOM PHARMACEUTICALS INC), worth $58M as of 2025-Q4. PHAT represents 0.4% of Carlyle Group Inc.'s portfolio.
Current Value
$58M
Current Shares
3.5M
Total Value Change
+$22.1M
Total Shares Change
0
Other major holders of PHAT: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Unchanged |
| 3.5M |
0.0% |
| $58M |
| 0.4% |
| $16.92 |
0 |
| 2025-Q3 | Unchanged | 3.5M | 0.0% | $41.1M | 0.9% | $11.33 | 0 |
| 2025-Q2 | Unchanged | 3.5M | 0.0% | $33.5M | 0.7% | $9.74 | 0 |
| 2025-Q1 | Unchanged | 3.5M | 0.0% | $21.9M | 0.6% | $6.60 | 0 |
| 2024-Q4 | Unchanged | 3.5M | 0.0% | $28.4M | 0.7% | $8.00 | 0 |
| 2024-Q3 | Unchanged | 3.5M | 0.0% | $63.2M | 6.6% | $17.52 | 0 |
| 2024-Q2 | Unchanged | 3.5M | 0.0% | $35.8M | 3.4% | $10.30 | 0 |